The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo. / Hansen, Henrik H; Weikop, Pia; Mikkelsen, Maria D; Rode, Frederik; Mikkelsen, Jens D.
I: Basic & Clinical Pharmacology & Toxicology Online, Bind 120, Nr. 1, 01.2017, s. 46-51.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The pan-Kv7 (KCNQ) Channel Opener Retigabine Inhibits Striatal Excitability by Direct Action on Striatal Neurons In Vivo
AU - Hansen, Henrik H
AU - Weikop, Pia
AU - Mikkelsen, Maria D
AU - Rode, Frederik
AU - Mikkelsen, Jens D
N1 - © 2016 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).
PY - 2017/1
Y1 - 2017/1
N2 - Central Kv7 (KCNQ) channels are voltage-dependent potassium channels composed of different combinations of four Kv7 subunits, being differently expressed in the brain. Notably, striatal dopaminergic neurotransmission is strongly suppressed by systemic administration of the pan-Kv7 channel opener retigabine. The effect of retigabine likely involves the inhibition of the activity in mesencephalic dopaminergic neurons projecting to the striatum, but whether Kv7 channels expressed in the striatum may also play a role is not resolved. We therefore assessed the effect of intrastriatal retigabine administration on striatal neuronal excitability in the rat determined by c-Fos immunoreactivity, a marker of neuronal activation. When retigabine was applied locally in the striatum, this resulted in a marked reduction in the number of c-Fos-positive neurons after a strong excitatory striatal stimulus induced by acute systemic haloperidol administration in the rat. The relative mRNA levels of Kv7 subunits in the rat striatum were found to be Kv7.2 = Kv7.3 = Kv7.5 > >Kv7.4. These data suggest that intrastriatal Kv7 channels play a direct role in regulating striatal excitability in vivo.
AB - Central Kv7 (KCNQ) channels are voltage-dependent potassium channels composed of different combinations of four Kv7 subunits, being differently expressed in the brain. Notably, striatal dopaminergic neurotransmission is strongly suppressed by systemic administration of the pan-Kv7 channel opener retigabine. The effect of retigabine likely involves the inhibition of the activity in mesencephalic dopaminergic neurons projecting to the striatum, but whether Kv7 channels expressed in the striatum may also play a role is not resolved. We therefore assessed the effect of intrastriatal retigabine administration on striatal neuronal excitability in the rat determined by c-Fos immunoreactivity, a marker of neuronal activation. When retigabine was applied locally in the striatum, this resulted in a marked reduction in the number of c-Fos-positive neurons after a strong excitatory striatal stimulus induced by acute systemic haloperidol administration in the rat. The relative mRNA levels of Kv7 subunits in the rat striatum were found to be Kv7.2 = Kv7.3 = Kv7.5 > >Kv7.4. These data suggest that intrastriatal Kv7 channels play a direct role in regulating striatal excitability in vivo.
KW - Animals
KW - Anticonvulsants
KW - Biomarkers
KW - Carbamates
KW - Corpus Striatum
KW - Cortical Excitability
KW - Dopamine Antagonists
KW - Drug Interactions
KW - Gene Expression Regulation
KW - Haloperidol
KW - Injections, Intraventricular
KW - KCNQ Potassium Channels
KW - Male
KW - Membrane Transport Modulators
KW - Nerve Tissue Proteins
KW - Neurons, Afferent
KW - Neurons, Efferent
KW - Nucleus Accumbens
KW - Phenylenediamines
KW - Protein Subunits
KW - Proto-Oncogene Proteins c-fos
KW - Rats, Wistar
KW - Synaptic Transmission
KW - Journal Article
U2 - 10.1111/bcpt.12636
DO - 10.1111/bcpt.12636
M3 - Journal article
C2 - 27377794
VL - 120
SP - 46
EP - 51
JO - Basic and Clinical Pharmacology and Toxicology
JF - Basic and Clinical Pharmacology and Toxicology
SN - 1742-7835
IS - 1
ER -
ID: 185688471